DEVA HOLDİNG A.Ş. Logo

DEVA HOLDİNG A.Ş.

Global manufacturer of human/veterinary pharmaceuticals, APIs, and medical ampoules.

DEVA

Overview

Corporate Details

ISIN(s):
TRADEVAW91E2
LEI:
959800K5PD9GB1EHW234
Country:
Spain
Address:
AVDA CANTABRIA S / N, 28660 Boadilla del Monte
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Established in 1958, DEVA Holding A.Ş. is a prominent pharmaceutical manufacturer. The company's core business activities include the development, production, and marketing of a diverse portfolio of healthcare products. Its primary product lines consist of pharmaceuticals for human use, active pharmaceutical ingredients (APIs), veterinary medicines, and medical ampoules. DEVA Holding operates internationally, utilizing various business models such as distributorships, out-licensing, and supply agreements to market its products globally.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-22 09:48
Board/Management Information
Company General Info Form
English 12.7 KB
2025-10-20 16:53
Board/Management Information
Yönetim Kurulu Üyesi belirlenmesi
Turkish 17.9 KB
2025-10-07 15:46
Board/Management Information
Bağımsız Yönetim Kurulu Üyesinin vefatı hakkında
Turkish 17.2 KB
2025-09-26 15:46
Capital/Financing Update
İpotek fekki
Turkish 17.3 KB
2025-08-22 09:39
Regulatory News Service
Yatırım teşvik belgesi kapatılması.
Turkish 18.1 KB
2025-08-21 13:57
Regulatory News Service
Kupon ödemesi
Turkish 27.2 KB
2025-08-20 15:50
Capital/Financing Update
TRSDEVA82629 ISIN kodlu tahvilin dördüncü kupon faiz oranı hakkında
English 27.3 KB
2025-08-15 22:46
Environmental & Social Information
Sürdürülebilirlik raporu
Turkish 15.3 KB
2025-08-15 18:35
Environmental & Social Information
TSRS Uyumlu 2024 Yılı Sürdürülebilirlik Raporu
Turkish 2.5 MB
2025-08-15 18:35
Environmental & Social Information
TSRS Uyumlu 2024 Yılı Sürdürülebilirlik Raporu
Turkish 15.2 KB
2025-08-15 18:33
Environmental & Social Information
Participation Finance Principles Information Form
English 52.6 KB
2025-08-15 18:32
Interim Report
Declaration of Responsibility.
Turkish 29.1 KB
2025-08-15 18:32
Interim Report
Activity Report
English 1.4 MB
2025-08-15 18:32
Management Discussion and Analysis
Activity Report
Turkish 1.6 MB
2025-08-15 18:32
Report Publication Announcement
Activity Report
English 13.2 KB

Automate Your Workflow. Get a real-time feed of all DEVA HOLDİNG A.Ş. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for DEVA HOLDİNG A.Ş.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for DEVA HOLDİNG A.Ş. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Elicera Therapeutics AB Logo
Develops CAR T-cell & oncolytic virus therapies for cancer, enhanced by its iTANK platform.
Sweden ELIC
Ellen AB Logo
Develops research-based probiotic and prebiotic products for women's intimate health and pH balance.
Sweden ELN
Enlivex Therapeutics Ltd. Logo
Developing cell therapy to restore immune balance for inflammatory diseases like sepsis.
Israel ENLV
Enorama Pharma AB Logo
Develops & makes consumer nicotine products & medicated gums, offering private label solutions.
Sweden ERMA
Develops novel therapeutics and APIs for oncology, inflammation, and respiratory diseases.
South Korea 183490
Enzymatica AB Logo
Develops medical devices with patented enzyme technology to treat upper respiratory infections.
Sweden ENZY
Developing alopecia therapies, skin regeneration products, and preclinical CRO services.
South Korea 446440
EQL Pharma AB Logo
Develops and sells cost-efficient niche generic medicines for the Nordic healthcare market.
Sweden EQL
ERYTECH Pharma S.A. Logo
Developing phage therapies to combat antibiotic-resistant bacterial infections.
France ERYP
EuBiologics Co., Ltd. Logo
Develops vaccines for global public health and provides biopharmaceutical CRMO services.
South Korea 206650

Talk to a Data Expert

Have a question? We'll get back to you promptly.